Consolidated Financial Results

for the Three Months Ended June 30, 2023

[Japanese GAAP]

August 3, 2023

Company name: ARAKAWA CHEMICAL INDUSTRIES, LTD.

Stock exchange listing: Tokyo Stock Exchange

Code number: 4968

URL: https://www.arakawachem.co.jp/

Representative: Takashi Une, Representative Director and President

Contact: Toru Nobuhiro, Managing Director and General Manager of Administrative H.Q.

Phone: +81-6-6209-8500

Scheduled date of filing quarterly securities report: August 9, 2023

Scheduled date of commencing dividend payments: -

Availability of supplementary explanatory materials on quarterly financial results: Available

Schedule of quarterly financial results briefing session: Not scheduled

(Amounts of less than one million yen are rounded down.)

1. Consolidated Financial Results for the Three Months Ended June 30, 2023 (April 1, 2023 - June 30, 2023)

(1) Consolidated Operating Results

(% indicates changes from the previous corresponding period.)

Net sales

Operating profit

Ordinary profit

Profit attributable

to owners of parent

Three months ended

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

June 30, 2023

17,298

(18.3)

(834)

-

(670)

-

(314)

-

June 30, 2022

21,161

7.7

571

(66.4)

722

(60.5)

376

(70.4)

(Note) Comprehensive income: Three months ended June 30, 2023: ¥ 212 million [(71.5)%]

Three months ended June 30, 2022: ¥ 743 million [(63.7)%]

Basic earnings

Diluted earnings

per share

per share

Three months ended

Yen

Yen

June 30, 2023

(15.84)

-

June 30, 2022

19.00

-

(2) Consolidated Financial Position

Total assets

Net assets

Equity ratio

Millions of yen

Millions of

yen

%

As of June 30, 2023

118,322

56,264

45.9

As of March 31, 2023

119,035

56,509

45.4

(Reference) Equity: As of June 30, 2023: ¥ 54,274 million As of March 31, 2023: ¥ 54,082 million

2. Dividends

Annual dividends

1st quarter-end

2nd quarter-end

3rd quarter-end

Year-end

Total

Yen

Yen

Yen

Yen

Yen

Fiscal year ended

-

24.00

-

24.00

48.00

March 31, 2023

Fiscal year ending

-

March 31, 2024

Fiscal year ending

March 31, 2024

24.00

-

24.00

48.00

(Forecast)

(Note) Revision to the forecast for dividends announced most recently: None

3. Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2024 (April 1, 2023 - March 31, 2024)

(% indicates changes from the previous corresponding period.)

Profit attributable

Basic earnings

Net sales

Operating profit

Ordinary profit

to owners of

per share

parent

Millions of yen

%

Millions of yen

%

Millions of yen

%

Millions of yen

%

Yen

First half

40,000

(4.1)

(2,000)

(2,100)

(1,800)

(90.73)

(cumulative)

Full year

83,000

4.5

(1,800)

(2,000)

(1,800)

(90.73)

(Note) Revision to the financial results forecast announced most recently: None

* Notes:

  1. Changes in significant subsidiaries during the period under review: None (Changes in specified subsidiaries resulting in changes in scope of consolidation) Newly included: - companies (Company name)
    Excluded: - companies (Company name)
  2. Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements:
    None
  3. Changes in accounting policies, changes in accounting estimates and retrospective restatement
    1. Changes in accounting policies due to the revision of accounting standards: None
    2. Changes in accounting policies other than 1) above: None
    3. Changes in accounting estimates: None
    4. Retrospective restatement: None
  4. Total number of issued shares (common shares)
    1. Total number of issued shares at the end of the period (including treasury shares):

June 30, 2023:

20,652,400 shares

March 31, 2023:

20,652,400 shares

2) Total number of treasury shares at the end of the period:

June 30, 2023:

813,491 shares

March 31, 2023:

813,491 shares

3) Average number of shares during the period:

Three months ended June 30, 2023:

19,838,909 shares

Three months ended June 30, 2022:

19,839,009 shares

  • These quarterly consolidated financial results are outside the scope of quarterly review by certified public accountants or an audit firm.
  • Explanation on the proper use of financial results forecast and other special notes

Forward-looking statements, including financial results forecasts, contained in this document are based on information currently available to the Company and certain assumptions deemed reasonable. Therefore, these statements do not constitute a guarantee that they will be realized. Actual results may differ materially from these statements due to various factors.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Arakawa Chemical Industries Ltd. published this content on 03 August 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 August 2023 07:29:11 UTC.